[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Herpes Zoster Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: C8B8424E6E13EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Herpes Zoster Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Herpes Zoster Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • Roche
  • Novartis
  • Merck
  • GlaxoSmithKline
  • Abbott Laboratories
  • Astellas Pharma
  • Bausch Health Companies
  • Teva Pharmaceutical
  • Foamix Pharmaceuticals
Market segment by Type, the product can be split into
  • Oral
  • Topical
  • Others
Market segment by Application, split into
  • Hospitals
  • Clinics
  • Home Care Settings
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Herpes Zoster Treatment status, future forecast, growth opportunity, key market and key players.
  • To present the Herpes Zoster Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Herpes Zoster Treatment are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Herpes Zoster Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Herpes Zoster Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral
  1.4.3 Topical
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Herpes Zoster Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Home Care Settings
1.6 Coronavirus Disease 2019 (Covid-19): Herpes Zoster Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Herpes Zoster Treatment Industry
    1.6.1.1 Herpes Zoster Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Herpes Zoster Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Herpes Zoster Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Herpes Zoster Treatment Market Perspective (2015-2026)
2.2 Herpes Zoster Treatment Growth Trends by Regions
  2.2.1 Herpes Zoster Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Herpes Zoster Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Herpes Zoster Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Herpes Zoster Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Herpes Zoster Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Herpes Zoster Treatment Players by Market Size
  3.1.1 Global Top Herpes Zoster Treatment Players by Revenue (2015-2020)
  3.1.2 Global Herpes Zoster Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Herpes Zoster Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Herpes Zoster Treatment Market Concentration Ratio
  3.2.1 Global Herpes Zoster Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Herpes Zoster Treatment Revenue in 2019
3.3 Herpes Zoster Treatment Key Players Head office and Area Served
3.4 Key Players Herpes Zoster Treatment Product Solution and Service
3.5 Date of Enter into Herpes Zoster Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Herpes Zoster Treatment Historic Market Size by Type (2015-2020)
4.2 Global Herpes Zoster Treatment Forecasted Market Size by Type (2021-2026)

5 HERPES ZOSTER TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Herpes Zoster Treatment Market Size by Application (2015-2020)
5.2 Global Herpes Zoster Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Herpes Zoster Treatment Market Size (2015-2020)
6.2 Herpes Zoster Treatment Key Players in North America (2019-2020)
6.3 North America Herpes Zoster Treatment Market Size by Type (2015-2020)
6.4 North America Herpes Zoster Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Herpes Zoster Treatment Market Size (2015-2020)
7.2 Herpes Zoster Treatment Key Players in Europe (2019-2020)
7.3 Europe Herpes Zoster Treatment Market Size by Type (2015-2020)
7.4 Europe Herpes Zoster Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Herpes Zoster Treatment Market Size (2015-2020)
8.2 Herpes Zoster Treatment Key Players in China (2019-2020)
8.3 China Herpes Zoster Treatment Market Size by Type (2015-2020)
8.4 China Herpes Zoster Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Herpes Zoster Treatment Market Size (2015-2020)
9.2 Herpes Zoster Treatment Key Players in Japan (2019-2020)
9.3 Japan Herpes Zoster Treatment Market Size by Type (2015-2020)
9.4 Japan Herpes Zoster Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Herpes Zoster Treatment Market Size (2015-2020)
10.2 Herpes Zoster Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Herpes Zoster Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Herpes Zoster Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Herpes Zoster Treatment Market Size (2015-2020)
11.2 Herpes Zoster Treatment Key Players in India (2019-2020)
11.3 India Herpes Zoster Treatment Market Size by Type (2015-2020)
11.4 India Herpes Zoster Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Herpes Zoster Treatment Market Size (2015-2020)
12.2 Herpes Zoster Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Herpes Zoster Treatment Market Size by Type (2015-2020)
12.4 Central & South America Herpes Zoster Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Roche
  13.1.1 Roche Company Details
  13.1.2 Roche Business Overview and Its Total Revenue
  13.1.3 Roche Herpes Zoster Treatment Introduction
  13.1.4 Roche Revenue in Herpes Zoster Treatment Business (2015-2020))
  13.1.5 Roche Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Herpes Zoster Treatment Introduction
  13.2.4 Novartis Revenue in Herpes Zoster Treatment Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Merck
  13.3.1 Merck Company Details
  13.3.2 Merck Business Overview and Its Total Revenue
  13.3.3 Merck Herpes Zoster Treatment Introduction
  13.3.4 Merck Revenue in Herpes Zoster Treatment Business (2015-2020)
  13.3.5 Merck Recent Development
13.4 GlaxoSmithKline
  13.4.1 GlaxoSmithKline Company Details
  13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.4.3 GlaxoSmithKline Herpes Zoster Treatment Introduction
  13.4.4 GlaxoSmithKline Revenue in Herpes Zoster Treatment Business (2015-2020)
  13.4.5 GlaxoSmithKline Recent Development
13.5 Abbott Laboratories
  13.5.1 Abbott Laboratories Company Details
  13.5.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.5.3 Abbott Laboratories Herpes Zoster Treatment Introduction
  13.5.4 Abbott Laboratories Revenue in Herpes Zoster Treatment Business (2015-2020)
  13.5.5 Abbott Laboratories Recent Development
13.6 Astellas Pharma
  13.6.1 Astellas Pharma Company Details
  13.6.2 Astellas Pharma Business Overview and Its Total Revenue
  13.6.3 Astellas Pharma Herpes Zoster Treatment Introduction
  13.6.4 Astellas Pharma Revenue in Herpes Zoster Treatment Business (2015-2020)
  13.6.5 Astellas Pharma Recent Development
13.7 Bausch Health Companies
  13.7.1 Bausch Health Companies Company Details
  13.7.2 Bausch Health Companies Business Overview and Its Total Revenue
  13.7.3 Bausch Health Companies Herpes Zoster Treatment Introduction
  13.7.4 Bausch Health Companies Revenue in Herpes Zoster Treatment Business (2015-2020)
  13.7.5 Bausch Health Companies Recent Development
13.8 Teva Pharmaceutical
  13.8.1 Teva Pharmaceutical Company Details
  13.8.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  13.8.3 Teva Pharmaceutical Herpes Zoster Treatment Introduction
  13.8.4 Teva Pharmaceutical Revenue in Herpes Zoster Treatment Business (2015-2020)
  13.8.5 Teva Pharmaceutical Recent Development
13.9 Foamix Pharmaceuticals
  13.9.1 Foamix Pharmaceuticals Company Details
  13.9.2 Foamix Pharmaceuticals Business Overview and Its Total Revenue
  13.9.3 Foamix Pharmaceuticals Herpes Zoster Treatment Introduction
  13.9.4 Foamix Pharmaceuticals Revenue in Herpes Zoster Treatment Business (2015-2020)
  13.9.5 Foamix Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Herpes Zoster Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Herpes Zoster Treatment Revenue
Table 3. Ranking of Global Top Herpes Zoster Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Herpes Zoster Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Topical
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Herpes Zoster Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Herpes Zoster Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Herpes Zoster Treatment Players to Combat Covid-19 Impact
Table 13. Global Herpes Zoster Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Herpes Zoster Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Herpes Zoster Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Herpes Zoster Treatment Market Share by Regions (2015-2020)
Table 17. Global Herpes Zoster Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Herpes Zoster Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Herpes Zoster Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Herpes Zoster Treatment Players
Table 24. Global Herpes Zoster Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Herpes Zoster Treatment Market Share by Players (2015-2020)
Table 26. Global Top Herpes Zoster Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoster Treatment as of 2019)
Table 27. Global Herpes Zoster Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Herpes Zoster Treatment Product Solution and Service
Table 30. Date of Enter into Herpes Zoster Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Herpes Zoster Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Herpes Zoster Treatment Market Size Share by Type (2015-2020)
Table 34. Global Herpes Zoster Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Herpes Zoster Treatment Market Size Share by Application (2015-2020)
Table 36. Global Herpes Zoster Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Herpes Zoster Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Herpes Zoster Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Herpes Zoster Treatment Market Share (2019-2020)
Table 40. North America Herpes Zoster Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Herpes Zoster Treatment Market Share by Type (2015-2020)
Table 42. North America Herpes Zoster Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Herpes Zoster Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Herpes Zoster Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Herpes Zoster Treatment Market Share (2019-2020)
Table 46. Europe Herpes Zoster Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Herpes Zoster Treatment Market Share by Type (2015-2020)
Table 48. Europe Herpes Zoster Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Herpes Zoster Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Herpes Zoster Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Herpes Zoster Treatment Market Share (2019-2020)
Table 52. China Herpes Zoster Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Herpes Zoster Treatment Market Share by Type (2015-2020)
Table 54. China Herpes Zoster Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Herpes Zoster Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Herpes Zoster Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Herpes Zoster Treatment Market Share (2019-2020)
Table 58. Japan Herpes Zoster Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Herpes Zoster Treatment Market Share by Type (2015-2020)
Table 60. Japan Herpes Zoster Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Herpes Zoster Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Herpes Zoster Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Herpes Zoster Treatment Market Share (2019-2020)
Table 64. Southeast Asia Herpes Zoster Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Herpes Zoster Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Herpes Zoster Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Herpes Zoster Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Herpes Zoster Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Herpes Zoster Treatment Market Share (2019-2020)
Table 70. India Herpes Zoster Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Herpes Zoster Treatment Market Share by Type (2015-2020)
Table 72. India Herpes Zoster Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Herpes Zoster Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Herpes Zoster Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Herpes Zoster Treatment Market Share (2019-2020)
Table 76. Central & South America Herpes Zoster Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Herpes Zoster Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Herpes Zoster Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Herpes Zoster Treatment Market Share by Application (2015-2020)
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Product
Table 83. Roche Revenue in Herpes Zoster Treatment Business (2015-2020) (Million US$)
Table 84. Roche Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Herpes Zoster Treatment Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck Product
Table 93. Merck Revenue in Herpes Zoster Treatment Business (2015-2020) (Million US$)
Table 94. Merck Recent Development
Table 95. GlaxoSmithKline Company Details
Table 96. GlaxoSmithKline Business Overview
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Revenue in Herpes Zoster Treatment Business (2015-2020) (Million US$)
Table 99. GlaxoSmithKline Recent Development
Table 100. Abbott Laboratories Company Details
Table 101. Abbott Laboratories Business Overview
Table 102. Abbott Laboratories Product
Table 103. Abbott Laboratories Revenue in Herpes Zoster Treatment Business (2015-2020) (Million US$)
Table 104. Abbott Laboratories Recent Development
Table 105. Astellas Pharma Company Details
Table 106. Astellas Pharma Business Overview
Table 107. Astellas Pharma Product
Table 108. Astellas Pharma Revenue in Herpes Zoster Treatment Business (2015-2020) (Million US$)
Table 109. Astellas Pharma Recent Development
Table 110. Bausch Health Companies Company Details
Table 111. Bausch Health Companies Business Overview
Table 112. Bausch Health Companies Product
Table 113. Bausch Health Companies Revenue in Herpes Zoster Treatment Business (2015-2020) (Million US$)
Table 114. Bausch Health Companies Recent Development
Table 115. Teva Pharmaceutical Business Overview
Table 116. Teva Pharmaceutical Product
Table 117. Teva Pharmaceutical Company Details
Table 118. Teva Pharmaceutical Revenue in Herpes Zoster Treatment Business (2015-2020) (Million US$)
Table 119. Teva Pharmaceutical Recent Development
Table 120. Foamix Pharmaceuticals Company Details
Table 121. Foamix Pharmaceuticals Business Overview
Table 122. Foamix Pharmaceuticals Product
Table 123. Foamix Pharmaceuticals Revenue in Herpes Zoster Treatment Business (2015-2020) (Million US$)
Table 124. Foamix Pharmaceuticals Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Herpes Zoster Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Topical Features
Figure 4. Others Features
Figure 5. Global Herpes Zoster Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Home Care Settings Case Studies
Figure 9. Herpes Zoster Treatment Report Years Considered
Figure 10. Global Herpes Zoster Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Herpes Zoster Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Herpes Zoster Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Herpes Zoster Treatment Market Share by Players in 2019
Figure 15. Global Top Herpes Zoster Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoster Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Herpes Zoster Treatment Revenue in 2019
Figure 17. North America Herpes Zoster Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Herpes Zoster Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Herpes Zoster Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Herpes Zoster Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Herpes Zoster Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Herpes Zoster Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Herpes Zoster Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Roche Revenue Growth Rate in Herpes Zoster Treatment Business (2015-2020)
Figure 26. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Novartis Revenue Growth Rate in Herpes Zoster Treatment Business (2015-2020)
Figure 28. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Merck Revenue Growth Rate in Herpes Zoster Treatment Business (2015-2020)
Figure 30. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GlaxoSmithKline Revenue Growth Rate in Herpes Zoster Treatment Business (2015-2020)
Figure 32. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Abbott Laboratories Revenue Growth Rate in Herpes Zoster Treatment Business (2015-2020)
Figure 34. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Astellas Pharma Revenue Growth Rate in Herpes Zoster Treatment Business (2015-2020)
Figure 36. Bausch Health Companies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bausch Health Companies Revenue Growth Rate in Herpes Zoster Treatment Business (2015-2020)
Figure 38. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Teva Pharmaceutical Revenue Growth Rate in Herpes Zoster Treatment Business (2015-2020)
Figure 40. Foamix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Foamix Pharmaceuticals Revenue Growth Rate in Herpes Zoster Treatment Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed


More Publications